Evaluation of tumor angiogenesis with US: Imaging, Doppler, and contrast agents

Schor, 1983, Tumour angiogenesis, J Pathol, 141, 385, 10.1002/path.1711410315

Folkman, 1971, Isolation of a tumor factor responsible for angiogenesis, J Exp Med, 133, 275, 10.1084/jem.133.2.275

Folkman, 1990, What is the evidence that tumors are angiogenesis dependent?, J Natl Cancer Inst, 82, 4, 10.1093/jnci/82.1.4

Gasparini, 1995, Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool, J Clin Oncol, 13, 765, 10.1200/JCO.1995.13.3.765

Weidner, 1992, Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma [see comments], J Natl Cancer Inst, 84, 1875, 10.1093/jnci/84.24.1875

Weidner, 1991, Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma, N Engl J Med, 324, 1, 10.1056/NEJM199101033240101

Bigler, 1992, Neovascularization in carcinoma of the prostate: a quantitative morphometric study, Mod Pathol, 5, 50

Macchiarini, 1992, Relation of neovascularisation to metastasis of non-small-cell lung cancer, Lancet, 340, 145, 10.1016/0140-6736(92)93217-B

Jain, 1994, Barriers to drug delivery in solid tumors, Sci Am, 271, 58, 10.1038/scientificamerican0794-58

Cheng, 1999, Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma, Cancer, 85, 651, 10.1002/(SICI)1097-0142(19990201)85:3<651::AID-CNCR15>3.0.CO;2-9

Mattrey, 1998, High-resolution harmonic gray-scale imaging of normal and abnormal vessels and tissues in animals, Acad Radiol, 5, S63, 10.1016/S1076-6332(98)80062-7

Foltz, 1995, A pial window model for the intracranial study of human glioma microvascular function, Neurosurgery, 36, 976, 10.1227/00006123-199505000-00014

Miles, 1999, Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review, Eur J Radiol, 30, 198, 10.1016/S0720-048X(99)00012-1

Tanaka, 1990, Color Doppler flow imaging of liver tumors, AJR Am J Roentgenol, 154, 509, 10.2214/ajr.154.3.2154912

Taylor, 1987, Focal liver masses: differential diagnosis with pulsed Doppler US, Radiology, 164, 643, 10.1148/radiology.164.3.3039570

Zagar, 1998, Ultrasonic mapping of the micro-vasculature: signal alignment, Ultrasound Med Biol, 24, 809, 10.1016/S0301-5629(98)00042-8

El-Fallah, 1997, Ultrasonic measurement of breast tissue motion and the implications for velocity estimation, Ultrasound Med Biol, 23, 1047, 10.1016/S0301-5629(97)00079-3

Meyerowitz, 1996, Quantification of tumor vascularity and flow with amplitude color Doppler sonography in an experimental model: preliminary results, J Ultrasound Med, 15, 827, 10.7863/jum.1996.15.12.827

Ferrara, 1996, Estimation of blood velocity using high frequency ultrasound, IEEE Trans Ultrasound Ferr Freq Control, 43, 149, 10.1109/58.484474

Goertz, 2000, High frequency colour flow imaging of the microcirculation, Ultrasound Med Biol, 26, 63, 10.1016/S0301-5629(99)00101-5

Madjar, 1991, Continuous-wave and pulsed Doppler studies of the breast: clinical results and effect of transducer frequency, Ultrasound Med Biol, 17, 31, 10.1016/0301-5629(91)90006-I

Cosgrove, 1990, Color Doppler signals from breast tumors: work in progress, Radiology, 176, 175, 10.1148/radiology.176.1.2191364

Birdwell, 1997, Preliminary experience with power Doppler imaging of solid breast masses, AJR Am J Roentgenol, 169, 703, 10.2214/ajr.169.3.9275882

Carson, 1992, Enhanced color flow imaging of breast cancer vasculature: continuous wave Doppler and three-dimensional display, J Ultrasound Med, 11, 377, 10.7863/jum.1992.11.8.377

Rubin, 1997, Normalizing fractional moving blood volume estimates with power Doppler US: defining a stable intravascular point with the cumulative power distribution function, Radiology, 205, 757, 10.1148/radiology.205.3.9393532

Fleischer, 2000, Sonographic depiction of tumor vascularity and flow: from in vivo models to clinical applications, J Ultrasound Med, 19, 55, 10.7863/jum.2000.19.1.55

Ismail, 1997, Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival, Urology, 50, 906, 10.1016/S0090-4295(97)00403-2

Rifkin, 1993, Prostate: techniques, results, and potential applications of color Doppler US scanning, Radiology, 186, 509, 10.1148/radiology.186.2.7678467

Sudakoff, 1996, Color Doppler imaging and transrectal sonography of the prostatic fossa after radical prostatectomy: early experience, AJR Am J Roentgenol, 167, 883, 10.2214/ajr.167.4.8819374

Kelly, 1993, Prostate cancer and the role of color Doppler US, Radiology, 189, 153, 10.1148/radiology.189.1.7690489

Newman, 1995, Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site, Radiology, 195, 86, 10.1148/radiology.195.1.7534429

Cornud, 1997, Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions, Urology, 49, 709, 10.1016/S0090-4295(96)00632-2

Cho, 1998, Diffuse prostatic lesions: role of color Doppler and power Doppler ultrasonography, J Ultrasound Med, 17, 283, 10.7863/jum.1998.17.5.283

Okihara, 1997, Ultrasonic power Doppler imaging for prostatic cancer: a preliminary report, Tohoku J Exp Med, 182, 277, 10.1620/tjem.182.277

Burns, 1996, Harmonic imaging: principles and preliminary results, Angiology, 47, 63

Epstein, 1950, On the stability of gas bubbles in liquid-gas solutions, J Chem Phys, 18, 1505, 10.1063/1.1747520

Dayton, 1999, Optical and acoustical observations of the effects of ultrasound on contrast agents, IEEE Trans Ultrasound Ferr Freq Control, 46, 220, 10.1109/58.741536

Schrope, 1993, Second harmonic ultrasonic blood perfusion measurement, Ultrasound Med Biol, 19, 567, 10.1016/0301-5629(93)90080-8

De Jong, 1994, Higher harmonics of vibrating gasfilled microspheres. I. Simulations, Ultrasonics, 32, 447, 10.1016/0041-624X(94)90064-7

De Jong, 1994, Higher harmonics of vibrating gasfilled microspheres. II. Measurements, Ultrasonics, 32, 455, 10.1016/0041-624X(94)90065-5

Forsberg, 1996, On the feasibility of real-time, in vivo harmonic imaging with proteinaceous microspheres, J Ultrasound Med, 15, 853, 10.7863/jum.1996.15.12.853

Chang, 1996, Quantitative measurements of second harmonic Doppler using ultrasound contrast agents, Ultrasound Med Biol, 22, 1205, 10.1016/S0301-5629(96)00146-9

Tiemann, 1999, Real-time contrast echo assessment of myocardial perfusion at low emission power: first experimental and clinical results using power pulse inversion imaging, Echocardiography, 16, 799, 10.1111/j.1540-8175.1999.tb00132.x

Porter, 1995, Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms, Circulation, 92, 2391, 10.1161/01.CIR.92.9.2391

Colon, 1997, Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with FSO69 during fundamental and second harmonic imaging, J Am Soc Echocardiogr, 10, 602, 10.1016/S0894-7317(97)70022-1

Broillet, 1998, Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent, Invest Radiol, 33, 209, 10.1097/00004424-199804000-00003

Kaul, 1997, Myocardial contrast echocardiography: 15 years of research and development, Circulation, 96, 3745, 10.1161/01.CIR.96.10.3745

Sirlin, 1997, Effect of ultrasound transmit power on liver enhancement with Imagent® US, a PFC-stabilized microbubble contrast agent, Int J Imaging Sys Technol, 8, 82, 10.1002/(SICI)1098-1098(1997)8:1<82::AID-IMA10>3.0.CO;2-N

Wei, 1998, Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion, Circulation, 97, 473, 10.1161/01.CIR.97.5.473

Mattrey, 1998, The use of ultrasound contrast to quantify kidney perfusion with B-mode imaging, Radiology, 209, 461

Margaliot, 1999, Negative bolus indicator dilution measurement of microvascular blood flow in skeletal muscle and skin using ultrasound contrast agents

Brawer, 1994, Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity, Cancer, 73, 678, 10.1002/1097-0142(19940201)73:3<678::AID-CNCR2820730329>3.0.CO;2-6

Bostwick, 1996, Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies, Urology, 48, 47, 10.1016/S0090-4295(96)00149-5

Lissbrant, 1997, Vascular density is a predictor of cancer-specific survival in prostatic carcinoma, Prostate, 33, 38, 10.1002/(SICI)1097-0045(19970915)33:1<38::AID-PROS7>3.0.CO;2-5

Borre, 1998, Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting, Br J Cancer, 78, 940, 10.1038/bjc.1998.605

Brawer, 1996, Quantitative microvessel density: a staging and prognostic marker for human prostatic carcinoma, Cancer, 78, 345, 10.1002/(SICI)1097-0142(19960715)78:2<345::AID-CNCR25>3.0.CO;2-V

Kay, 1998, Prostate cancer microvessels: a novel method for three-dimensional reconstruction and analysis, Prostate, 37, 270, 10.1002/(SICI)1097-0045(19981201)37:4<270::AID-PROS9>3.0.CO;2-V

Louvar, 1998, Correlation of color Doppler flow in the prostate with tissue microvascularity, Cancer, 83, 135, 10.1002/(SICI)1097-0142(19980701)83:1<135::AID-CNCR18>3.0.CO;2-Y

Ragde, 1997, Transrectal ultrasound microbubble contrast angiography of the prostate, Prostate, 32, 279, 10.1002/(SICI)1097-0045(19970901)32:4<279::AID-PROS8>3.0.CO;2-E

Rifkin, 1997, Ultrasound contrast enhanced color Doppler: initial results in the evaluation of the prostate (abstr), Radiology, 205, 280

Blomley, 1997, Quantitation of enhanced transrectal ultrasound of the prostate: work in progress using the echo-enhancing agent Br1, Radiology, 205, 280

Eckersley, 1998, Quantitative microbubble enhanced transrectal ultrasound (TRUS) as a tool for monitoring anti-androgen therapy in prostate carcinoma: work in progress (abstr), Radiology, 209, 280

Halpern, 1999, Gray scale and Doppler evaluation of the prostate following administration of Imagent (abstr), J Ultrasound Med, 18, S43

Halpern, 1999, Initial experience with contrast-enhanced (Imagent) intermittent imaging and wideband harmonic imaging of the prostate, 76

Wilson, 2000, Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma and metastasis, Radiology, 215, 153, 10.1148/radiology.215.1.r00ap08153

Simpson, 1999, Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents, IEEE Trans Ultrasound Ferr Freq Control, 46, 372, 10.1109/58.753026

Kono, 1999, Visualization of tumor vessels with ultrasound contrast and the potential for quantitative analysis of relative tumor blood flow and fractional blood volume

Bartolozzi, 1998, Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US, Radiology, 209, 387, 10.1148/radiology.209.2.9807563

Solbiati, 1999, Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent—early experience, Radiology, 211, 643, 10.1148/radiology.211.3.r99jn06643

Christopher, 1996, A high-frequency continuous-wave Doppler ultrasound system for the detection of blood flow in the microcirculation, Ultrasound Med Biol, 22, 1191, 10.1016/S0301-5629(96)00153-6

Ferrara, 1996, Estimation of blood velocities with high-frequency ultrasound, IEEE Trans Ultrasound Ferr Freq Control, 43, 149, 10.1109/58.484474

Kruse, 1998, A swept-scanning mode for estimation of blood velocities in the microvasculature, IEEE Trans Ultrasound Ferr Freq Control, 45, 1437, 10.1109/58.738282

Goertz, 2000, High-frequency color flow imaging of the microcirculation, Ultrasound Med Biol, 26, 63, 10.1016/S0301-5629(99)00101-5

Vogt, 1997, Application of high frequency broadband ultrasound for high resolution blood flow measurements, 1243

Pavlin, 1992, Ultrasound biomicroscopy of anterior segment tumors, Ophthalmology, 99, 1220, 10.1016/S0161-6420(92)31820-2

Hoffmann, 1992, Malignant melanoma in 20-MHz B scan sonography, Dermatology, 185, 49, 10.1159/000247403

Turnbull, 1996, Ultrasound backscatter microscope analysis of mouse melanoma progression, Ultrasound Med Biol, 22, 845, 10.1016/0301-5629(96)00107-X

Sherar, 1987, Ultrasound backscatter microscopy images the internal structure of living tumour spheroids, Nature, 330, 493, 10.1038/330493a0

Berube, 1992, Use of a high frequency ultrasound microscope to image the action of 2-nitroimidazoles in multicellular spheroids, Br J Cancer, 65, 633, 10.1038/bjc.1992.137

Jimenez, 2000, Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1, Nat Med, 6, 41, 10.1038/71517

Czarnota, 1999, Ultrasound imaging of apoptosis: high-resolution non-invasive monitoring of programmed cell death in vitro, in situ and in vivo, Br J Cancer, 81, 520, 10.1038/sj.bjc.6690724

Barnhill, 1993, Regressing thin cutaneous malignant melanomas (less than or equal to 1.0 mm) are associated with angiogenesis, Am J Pathol, 143, 99

Brooks, 1994, Requirement of vascular integrin alpha v beta 3 for angiogenesis, Science, 264, 569, 10.1126/science.7512751

Carmeliet, 1996, Role of tissue factor in embryonic blood vessel development, Nature, 383, 73, 10.1038/383073a0

Moulton, 1999, Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice, Circulation, 99, 1726, 10.1161/01.CIR.99.13.1726

Wu, 1998, Binding and lysing of blood clots using MRX-408, Invest Radiol, 33, 880, 10.1097/00004424-199812000-00006

Takeuchi, 1999, Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): in vivo experimental echocardiographic studies, J Am Soc Echocardiogr, 12, 1015, 10.1016/S0894-7317(99)70096-9

Villanueva, 1998, Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells, Circulation, 98, 1, 10.1161/01.CIR.98.1.1

Murer, 1995, Targeting of acoustically reflective liposomes for tissue specific ultrasonic enhancement (abstr), Circulation, 92, 659

Demos, 1999, In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement, J Am Coll Cardiol, 33, 867, 10.1016/S0735-1097(98)00607-X

Lindner J, Dayton P, Ferrara K, Kaul S. Perseverance and acoustic properties of phagocytosed microbubbles: implications for inflammatory imaging. Circulation (in press).

Lanza, 1996, A novel site-targeted ultrasonic contrast agent with broad biomedical application, Circulation, 94, 3334, 10.1161/01.CIR.94.12.3334

Lanza, 1996, Acoustic enhancement of arterial thrombi in vivo following intravenous injection (abstr), Circulation, 94, 319

Lanza, 1997, High-frequency ultrasonic detection of thrombi with a targeted contrast system, Ultrasound Med Biol, 23, 863, 10.1016/S0301-5629(97)00046-X

Lanza, 1997, Site targeted magnetic resonance contrast enhancement of vascular thrombus with a novel particulate emulsion (abstr)

Lanza, 1998, In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy, J Acoust Soc Am, 104, 3665, 10.1121/1.423948

Price, 1998, Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound, Circulation, 98, 1264, 10.1161/01.CIR.98.13.1264

Unger, 1997, Ultrasound enhances gene expression of liposomal transfection, Invest Radiol, 32, 723, 10.1097/00004424-199712000-00001

Unger, 1998, Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent, Invest Radiol, 33, 886, 10.1097/00004424-199812000-00007

Hiser, 1998, Inhibition of carotid artery neointimal formation following balloon injury using ultrasound-targeted deposition of antisense to C-MYC protooncogene bound to intravenously delivered perfluorocarbon microbubbles (abstr), J Am Soc Echocardiogr, 11, 498

Tiukinhoy S, Mahowald M, Shively V, et al. Development of inherently acoustic plasmid-incorporated tissue-targeted cationic liposomes for directed gene delivery. J Clin Invest (in press).